Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Harvard Business School
Dow
Colorcon
Baxter

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Copley Pharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for COPLEY PHARM, and what generic and branded alternatives to COPLEY PHARM drugs are available?

COPLEY PHARM has fifteen approved drugs.



Summary for Copley Pharm
US Patents:0
Tradenames:7
Ingredients:7
NDAs:15

Drugs and US Patents for Copley Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Copley Pharm BROMPHERIL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 089116-001 Jan 22, 1987 DISCN No No   Start Trial   Start Trial
Copley Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088426-001 Apr 30, 1984 DISCN No No   Start Trial   Start Trial
Copley Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088423-001 Apr 30, 1984 DISCN No No   Start Trial   Start Trial
Copley Pharm ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 072967-001 Nov 22, 1991 DISCN No No   Start Trial   Start Trial
Copley Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088421-001 Apr 30, 1984 DISCN No No   Start Trial   Start Trial
Copley Pharm AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 088424-001 Apr 30, 1984 DISCN No No   Start Trial   Start Trial
Copley Pharm ALBUTEROL SULFATE albuterol sulfate SOLUTION;INHALATION 073307-001 Nov 27, 1991 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Boehringer Ingelheim
Merck
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.